Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Saroja Pharma Industries India Days Payable?
Saroja Pharma Industries IndiaNSE:SAROJA +3.15%15 Days Payable is 72.35 as of Mar. 2025, which is 59% above its 10-year median of 45.43. GuruFocus rates NSE:SAROJA with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 925 Drug Manufacturers companies, Saroja Pharma Industries India ranks worse than 58.49% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saroja Pharma Industries India Days Payable Chart
Saroja Pharma Industries India Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Days Payable
45.43
34.29
45.00
58.74
72.35
Saroja Pharma Industries India Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Days Payable
45.43
34.29
45.00
58.74
72.35
NSE:SAROJA vs ZTS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saroja Pharma Industries India's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saroja Pharma Industries India Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saroja Pharma Industries India's Days Payable distribution charts can be found below:
* The bar in red indicates where Saroja Pharma Industries India's Days Payable falls into.
Saroja Pharma Industries India Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saroja Pharma Industries India (NSE:SAROJA) has a Days Payable of 72.35 as of Mar. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Saroja Pharma Industries India and its competitors. This is 59% above median its historical median of 45.43. Over the past decade, Saroja Pharma Industries India's Days Payable has ranged from 34.29 to 72.35. According to the industry distribution chart, Saroja Pharma Industries India ranks #541 out of 925 companies in the Drug Manufacturers industry, placing it in the top 58.5%.
Is Saroja Pharma Industries India's Days Payable too high?
Saroja Pharma Industries India's current Days Payable of 72.35 is 59% above median its 10-year median of 45.43. Over the past 10 years, this metric has ranged from a low of 34.29 to a high of 72.35. The Drug Manufacturers industry median Days Payable is 88.85. Saroja Pharma Industries India's value of 72.35 is 18.6% below this industry median. Based on the distribution chart, Saroja Pharma Industries India ranks #541 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Saroja Pharma Industries India has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Saroja Pharma Industries India's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Saroja Pharma Industries India ranks #541 out of 925 companies for Days Payable. This places Saroja Pharma Industries India in the lower half of its industry. The industry median Days Payable is 88.85. Saroja Pharma Industries India's value of 72.35 is 18.6% below this benchmark. Historically, Saroja Pharma Industries India's own Days Payable has ranged from 34.29 to 72.35 over the past decade. While the company's 10-year median is 45.43 vs. the industry median of 88.85, Saroja Pharma Industries India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.85, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saroja Pharma Industries India's current Days Payable of 72.35 is 18.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Saroja Pharma Industries India and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saroja Pharma Industries India's current Days Payable is 72.35, which is 59% above median its own 10-year median of 45.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saroja Pharma Industries India stock overvalued right now?
Saroja Pharma Industries India (NSE:SAROJA) has a current Days Payable of 72.35. The current Days Payable is 72.35, which is 59% above median its 10-year median of 45.43 and 18.6% below the Drug Manufacturers industry median of 88.85. Saroja Pharma Industries India's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Saroja Pharma Industries India (NSE:SAROJA), the current Days Payable is 72.35 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
15GF Score
Get the complete analysis for NSE:SAROJA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAROJA has been successfully added to your 
